Cargando…
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
The combination of glucagon-like peptide-1 (GLP-1) with other gut hormones including the glucose-dependent insulinotropic polypeptide (GIP) has been explored to complement and enhance further the GLP-1 effects on glycemia and weight loss. Tirzepatide is the first dual GLP-1/GIP receptor co-agonist w...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for the Study of Obesity
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088547/ https://www.ncbi.nlm.nih.gov/pubmed/36750526 http://dx.doi.org/10.7570/jomes22067 |